Skip to main content
Equibles
ENTA logo

ENTA · Enanta Pharmaceuticals Inc · Debt

Track ENTA — free

Use ENTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.18 +0.18 (+1.50%) At close · Oct 27 Q2 2024 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$354.75M
Shares
29.13M
Volume · Oct 27 319.44K Avg daily vol (3M) 243.4K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 3,906,000 10-Q filed 2026-08-12
Noncurrent operating lease liabilities 2026-06-30 USD 51,750,000 10-Q filed 2026-08-12
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 15 filings 15 filers Visit website Investor relations